Skip to main content
Clinical Trials/NCT01956682
NCT01956682CompletedPhase 4

Hypoallergenic Infant Formula Containing Starch and the Probiotic: Effect on Gastric Emptying

University of Bari1 site in 1 country132 target enrollmentStarted: October 1, 2014Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
132
Locations
1
Primary Endpoint
Regurgitation

Study Overview

Brief Summary

The primary objective of this trial is to show that an hypoallergenic infant starter formula containing starch and the probiotic L. reuteri decreases the severity of regurgitation/spitting-up in infants presenting regurgitation/spitting-up , and who have taken it for 4 weeks, in comparison with a standard infant starter formula.

Detailed Description

The primary objective of this trial is to show that the test formula (HA formula + starch + L. reuteri) decreases the severity (frequency + volume) of regurgitation/spitting-up in infants and ultrasound gastric emptying time, compared to a classical infant starter formula.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
5 Days to 5 Months (Child)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Full term infant (37 weeks ≤ gestation ≤ 42 weeks)
  • •Age of infant between 5 days and 5 months
  • •Infant exclusively formula-fed at enrollment
  • •Presenting regurgitation/spitting-up according to the parents' perception
  • •Vandenplas score of at least 2 and maximum 5
  • •Having obtained the subject's legal representative's written informed consent

Exclusion Criteria

  • •Previous antireflux treatment
  • •Previous consumption of AR infant formula or external thickener
  • •Previous consumption of a formula with L. reuteri
  • •Cow's milk allergy symptoms according to medical decision
  • •Congenital illness or malformation that may affect growth
  • •Significant pre-natal and/or post-natal disease
  • •Newborn whose parents / caregivers cannot be expected to comply with study procedures
  • •Newborn currently participating or having participated in another clinical trial during the last 4 weeks prior to the beginning of this study.

Arms & Interventions

Infant formula

Active Comparator

HA formula + starch + L. reuteri

Intervention: HA formula + starch + L. reuteri (Dietary Supplement)

Standard Formula

Placebo Comparator

Standard Infant Formula

Outcomes

Primary Outcomes

Regurgitation

Time Frame: four weeks of treatment

The primary outcome is the difference in the proportions of improved subjects at four weeks of treatment between the treatment and control groups.

Secondary Outcomes

  • Regurgitation score(Four weeks treatment)
  • Stool frequency(Four weeks treatment)
  • compliance(four weeks intervention)
  • Growth(Four weeks of treatment)
  • Gastric empty rate(Four week treatment)
  • Financial and non-financial burden(Four week treatment)
  • Digestive tolerance(Four weeks treatment)

Investigators

Sponsor
University of Bari
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Flavia Indrio

M.D.

University of Bari

Study Sites (1)

Loading locations...

Similar Trials